2. Academic Validation
  3. In vitro activity of AR-709 against Streptococcus pneumoniae

In vitro activity of AR-709 against Streptococcus pneumoniae

  • Antimicrob Agents Chemother. 2008 Mar;52(3):1182-3. doi: 10.1128/AAC.01332-07.
W T M Jansen 1,  A Verel,  J Verhoef,  D Milatovic
Affiliations

Affiliation

  • 1 University Medical Center Utrecht, Medical Microbiology Dept., G 04.614, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. w.t.m.jansen@umcutrecht.nl
PMID: 18180358 DOI: 10.1128/AAC.01332-07
Abstract

We investigated the in vitro activity of AR-709, a novel diaminopyrimidine Antibiotic currently in development for treatment of community-acquired upper and lower respiratory tract infections, against 151 Streptococcus pneumoniae strains from various European countries. AR-709 showed excellent activity against both drug-susceptible and multidrug-resistant pneumococci.

Figures
Products